Elevance Health Inc, the American health insurance provider is undervalued.
On revenue of 156.595 billion USD for the calendar 2022, which grew by 12.95 % year on year, net profit margin of 3.85 % Elevance Health has too much unlocked value. Elevance Health's revenue grew by 50 % in the last five calendar reported years up to 2022 and the net profit margin stayed at 4 % on average.
Elevance Health's intrinsic value is 270 billion USD, compared with Elevance Health's current market capitalization of 108.30 billion USD.
At a trailing Price/Earnings of 16.46 Elevance Health is undervalued, given the logical and Wolfteam Ltd.'s projections for future revenue growth and stable profitability.
No comments:
Post a Comment